Literature DB >> 9178936

Selective antitumor activity in vitro from marine algae from Japan coasts.

H Harada1, T Noro, Y Kamei.   

Abstract

In vitro selective antitumor activity was tested as a general screening parameter for biologically active substances from a wide range of species of seaweed, 1446 samples of 306 species of marine algae from Japan's coasts. The algae extracts were prepared successively first by phosphate buffered saline (PBS) and then by methanol, and then tested for in vitro selective antitumor activity against murine lymphoid leukemia L1210 cells and for low cytotoxic activity against NIH-3T3 normal cells. Strong cytotoxic activity against L1210 cells was found in 47 species of algae, also showing similar cytotoxicity to mouse NIH-3T3 normal cells. However, four species of green algae showed strong activity specifically against L1210 cells, with low cytotoxicity to normal cells. Such selective activity was conspicuous in two brown and two green algae extracts. In particular, methanol extracts from the green alga, Cladophoropsis vaucheriaeformis, exhibited high viability (86%) to normal cells, showing selective cytotoxicity to tumor cells. This alga extract was no cytocidalic, but cytostatic against L1210 cells. Furthermore, the results of a cytotoxic spectrum test with 9 cell lines including those of L1210 and NIH-3T3 demonstrated that this extract acted strongly only against leukemic cell lines L1210 and P388.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9178936     DOI: 10.1248/bpb.20.541

Source DB:  PubMed          Journal:  Biol Pharm Bull        ISSN: 0918-6158            Impact factor:   2.233


  15 in total

1.  Selective cytotoxicity of marine algae extracts to several human leukemic cell lines.

Authors:  H Harada; Y Kamei
Journal:  Cytotechnology       Date:  1997-11       Impact factor: 2.058

2.  Neurite outgrowth promoting activity of marine algae from Japan against rat adrenal medulla pheochromocytoma cell line, PC12D.

Authors:  Yuto Kamei; Atsuko Sagara
Journal:  Cytotechnology       Date:  2002-11       Impact factor: 2.058

3.  Telomerase inhibiting activity in vitro from natural resources, marine algae extracts.

Authors:  K Kanegawa; H Harada; H Myouga; Y Katakura; S Shirahata; Y Kamei
Journal:  Cytotechnology       Date:  2000-07       Impact factor: 2.058

4.  In vitro promoting activity of human interferon β production by extracts of marine algae from Japan.

Authors:  T Nakano; T Noro; Y Kamei
Journal:  Cytotechnology       Date:  1997-11       Impact factor: 2.058

5.  Antioxidant and anticancer activities of selected persian gulf algae.

Authors:  F Namvar; J Baharara; A A Mahdi
Journal:  Indian J Clin Biochem       Date:  2013-04-17

Review 6.  Emerging targets in lipid-based therapy.

Authors:  Stephanie C Tucker; Kenneth V Honn
Journal:  Biochem Pharmacol       Date:  2012-12-20       Impact factor: 5.858

7.  Antioxidant, antiproliferative, and antiangiogenesis effects of polyphenol-rich seaweed (Sargassum muticum).

Authors:  Farideh Namvar; Rosfarizan Mohamad; Javad Baharara; Saeedeh Zafar-Balanejad; Fahimeh Fargahi; Heshu Sulaiman Rahman
Journal:  Biomed Res Int       Date:  2013-09-04       Impact factor: 3.411

8.  Correlation of antiangiogenic, antioxidant and cytotoxic activities of some Sudanese medicinal plants with phenolic and flavonoid contents.

Authors:  Loiy Elsir A Hassan; Mohamed B Khadeer Ahamed; Aman S Abdul Majid; Hussein M Baharetha; Nahdzatul S Muslim; Zeyad D Nassar; Amin M S Abdul Majid
Journal:  BMC Complement Altern Med       Date:  2014-10-20       Impact factor: 3.659

9.  Cytotoxic activity of ten algae from the Persian Gulf and Oman Sea on human breast cancer cell lines; MDA-MB-231, MCF-7, and T-47D.

Authors:  Nasrollah Erfani; Zahra Nazemosadat; Mahmoodreza Moein
Journal:  Pharmacognosy Res       Date:  2015 Apr-Jun

10.  Cytotoxic effect of clerosterol isolated from Codium fragile on A2058 human melanoma cells.

Authors:  Areum Daseul Kim; Youngki Lee; Sang-Hyuck Kang; Gi Young Kim; Hye Sun Kim; Jin Won Hyun
Journal:  Mar Drugs       Date:  2013-02-06       Impact factor: 5.118

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.